B 793 (Rivastigmine Tartrate 1.5 mg)
Pill with imprint B 793 is Yellow, Capsule-shape and has been identified as Rivastigmine Tartrate 1.5 mg. It is supplied by Breckenridge Pharmaceutical, Inc.
Rivastigmine is used in the treatment of alzheimer's disease; parkinson's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for B 793
Rivastigmine Tartrate
- Imprint
- B 793
- Strength
- 1.5 mg
- Color
- Yellow
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Cholinesterase inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Breckenridge Pharmaceutical, Inc.
- National Drug Code (NDC)
- 51991-0793
- Inactive Ingredients
-
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
silicon dioxide,
gelatin,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related Images for "B 793"
More about rivastigmine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (34)
- Drug images
- Pricing & coupons
- Drug class: cholinesterase inhibitors
Patient resources
- Drug Information
- Rivastigmine transdermal
- Rivastigmine (Advanced Reading)
- Rivastigmine Transdermal (Advanced Reading)
- Rivastigmine Capsules
- Other brands
- Exelon
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.